Contactin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Contactin 2 Protein | |
|---|---|
| Protein Name | Contactin 2 (axonin-1, TAG-1) |
| Gene | CNTN2 |
| UniProt ID | Q9H5Y1 |
| PDB ID | 4JF0, 4JES |
| Molecular Weight | 135 kDa (1048 aa) |
| Subcellular Localization | Cell membrane, Axon surface |
| Protein Family | Immunoglobulin superfamily |
Contactin 2 Protein is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, or stress response mechanisms.
Dysregulation or mutations in this gene/protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
Contactin 2 is a cell surface glycoprotein with multiple immunoglobulin (Ig) and fibronectin type III (FNIII) domains:
The GPI anchor allows dynamic relocalization to lipid rafts and release as soluble protein.
Contactin 2 plays crucial roles in nervous system development:
Key interactions:
| Approach | Drug/Agent | Status | Mechanism |
|---|---|---|---|
| Antibody therapy | Anti-CNTN2 antibodies | Preclinical | Modulate adhesion |
| Peptide mimetics | L1CAM fragments | Preclinical | Promote connectivity |
| Cell therapy | Oligodendrocyte precursors | Preclinical | Enhance myelination |
| Gene therapy | AAV-CNTN2 | Preclinical | Restore expression |
The study of Contactin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.